Immunological properties of dehydroepiandrosterone, its conjugates, and metabolites

Annals of the New York Academy of Sciences

Volumn 876, Issue , 1999, Pages 91-101

  Bradlow, H Leon ^a,b   Murphy, Justin ^a   Byrne, James J ^a  

^a AMUR Pharmaceuticals Inc   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ANDROSTANEDIOL; DRUG METABOLITE; ETIOCHOLANOLONE; ETIOCHOLANONE; GLUCOCORTICOID; PRASTERONE; PRASTERONE SULFATE; STEROID; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; IMMUNE RESPONSE; INFLAMMATION; MALE; MOUSE; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032781753     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07627.x     Document Type: Conference Paper

References (21)

1. 1. LEMUS, A. E., J. ENRIQUEZ, G. A. GARCIA, I. GRILLASCA & G. PEREZ-PALACIOS, 1997. 5-alpha-reduction of norethisterone enhances its binding affinity for androgen receptors but diminishes its androgenic potency. J. Ster. Biochem. Mol. Biol. 60: 121-129.
2. 2. SASSA, S., H. L. BRADLOW & A. KAPPAS. 1979. Steroid induction of Δ-amino-levulinic acid synthase and porphyrins in liver. Structure-activity studies and the permissive effects of hormones on the induction process. J. Biol. Chem. 25: 10011-10020.
3. 3. KAPPAS, A., L. HELLMAN, D. K. FUKUSHIMA & T. F. GALLAGHER. 1957. The pyrogenic effect of etiocholanolone. J. Clin. Endocrinol. Metab. 17: 451-454.
4. 4. KAPPAS, A., L. HELLMAN, D. K. FUKUSHIMA & T. F. GALLAGHER. 1958. The thermogenic effect and metabolic fate of etiocholanolone in man. J. Clin. Endocrinol. Metab. 18: 1043-1055.
5. 5. KAPPAS, A. & B. RATKOVITS. 1960. Species specificity of steroid-induced fever. J. Clin. Endocrinol. Metab. 20: 898-900.
6. 6. PALMER, R. & A. KAPPAS. 1963. Fever-producing action of steroids. Med. Clin. North Am. 47: 101-112.
7. a mice by dehydroepiandrosterone. Lipids 12: 409-413.
8. 8. SHEPARD, A & M. P. CLEARY. 1984. Dehydroepiandrosterone treatment in Zucker rats. Am. J. Physiol. 24: E123-E128.
9. w). J. Exp. Zool. 242: 67-74.
10. 10. CLEARY, M. P., A. SHEPARD, J. ZISKE & A. SCHWARTZ. 1983. Effect of dehydroepiandrosterone on body weight and food intake in rats. Nutr. Behav. 1: 127-136.
11. 11. COLEMAN, D. L., E. H. LEITER & N. APPLEZWEIG. 1984. Therapeutic effects of dehydroepiandrosterone metabolites in diabetes mutant mice. Endocrinology 115: 239-243.
12. 12. COLEMAN, D. L. 1985. Antiobesity effects of etiocholanolones in diabetes (db), viable yellow (Avy), and normal mice. Endocrinology 117: 2279-2283.
13. 13. COLEMAN, D. L., E. H. LEITER & R. W. SCHWIZER. 1982. Therapeutic benefits of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 31: 830-835.
14. 14. SCHWARZ, A. G. 1979. Inhibition of spontaneous breast cancer formation in female C3H Avy/a mice by long term treatment with dehydroepiandrosterone. Cancer Res. 39: 1139-1143.
15. 15. HELLMAN, L., B. ZUMOFF, M. A. COHN, A. SAKAMOTO, K. C. FRANCIS, D. G. C. CLARK, D. K. FUKUSHIMA & T. F. GALLAGHER. 1976. An anti-tumor property of etiocholanolone in man. Trans. Am. Coll. Physicians 59: 323-330.
16. 16. LUCAS, J. A., S. A. AHMED, M. L. CASEY & P. C. MACDONALD. 1985. Prevention of autoantibody formation and prolonged survival in New Zealand black/New Zealand F1 mice fed dehydroepiandrosterone. Clin. Invest. 75: 2091-2093.
17. 17. LORIA, R. M., T. H. INGE, S. S. COOK, A. K. SZAKAI & W. REGELSON. 1988. Protection against acute viral infection with the native steroid dehydroepiandrosterone (DHEA). J. Med. Virol. 26: 301-314.
18. 18. BAINS, S. K., S. M. GARDINER, K. MANNWEIUER, D. GILLET & C. G. GIBSON. 1985. Immunochemical study on the contribution of hypolipidaemic-induced cytochrome P-452 to the metabolism of lauric acid and arachidonic acid. Biochem. Pharmacol. 334: 3221-3229.
19. 19. ROSS, P. M., J. A. WALBERG & H. L. BRADLOW. 1988. Glucocorticoid effects on delayed hypersensitivity and on the cutaneous response to ultraviolet light in the mouse. J. Invest. Dermatol. 90: 366-371.
20. 20. DERKSEN, R. H. 1998. Dehydroisoandrosterone (DHEA) and systemic lupus erythematosus. Semin. Arthritis Rheum. 27: 335-347.
21. 21. VAN VOLLENHOVEN, R. F., L. M. MORABITO, E. G. ENGLEMAN & J. L. MCGUIRE. 1998. Treatment of systemic lupus erythematosus with dehydroisoandrosterone: 50 patients treated up to 12 months. J. Rheumatol. 25: 285-289.